Application Sponsors
ANDA 087845 | MALLINCKRODT INC | |
Marketing Status
Application Products
001 | TABLET;ORAL | 25MG | 0 | TOFRANIL | IMIPRAMINE HYDROCHLORIDE |
FDA Submissions
| ORIG | 1 | AP | 1984-05-22 | |
LABELING; Labeling | SUPPL | 9 | AP | 1993-02-02 | |
LABELING; Labeling | SUPPL | 12 | AP | 1994-12-20 | |
LABELING; Labeling | SUPPL | 14 | AP | 1998-09-01 | |
LABELING; Labeling | SUPPL | 20 | AP | 2004-08-31 | |
LABELING; Labeling | SUPPL | 21 | AP | 2005-06-09 | |
LABELING; Labeling | SUPPL | 22 | AP | 2005-09-12 | |
LABELING; Labeling | SUPPL | 24 | AP | 2007-06-25 | |
LABELING; Labeling | SUPPL | 25 | AP | 2007-09-27 | |
LABELING; Labeling | SUPPL | 27 | AP | 2014-07-17 | STANDARD |
LABELING; Labeling | SUPPL | 28 | AP | 2017-06-29 | STANDARD |
Submissions Property Types
SUPPL | 27 | Null | 15 |
SUPPL | 28 | Null | 15 |
TE Codes
CDER Filings
MALLINCKRODT INC
cder:Array
(
[0] => Array
(
[ApplNo] => 87845
[companyName] => MALLINCKRODT INC
[docInserts] => ["",""]
[products] => [{"drugName":"TOFRANIL","activeIngredients":"IMIPRAMINE HYDROCHLORIDE","strength":"25MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"TOFRANIL","submission":"IMIPRAMINE HYDROCHLORIDE","actionType":"25MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)